You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hu1928-Hu20BB

Showing 1 - 25 of 3,732
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HFRS (Hemorrhagic Fever With Renal Syndrome) Trial in China (IVIG 20g/d, IVIG 10g/d)

Recruiting
  • HFRS (Hemorrhagic Fever With Renal Syndrome)
  • IVIG 20g/d
  • IVIG 10g/d
  • Guangshui, Hu Bei Province, China
  • +8 more
Aug 22, 2023

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)

Not yet recruiting
  • Coronary Artery Disease
  • BioMatrix Alpha
  • Birmingham, United Kingdom
  • +5 more
Mar 23, 2023

Accidental Fall, Quality of Life, Aged Trial in Hull, Maidstone (Fire and Rescue Service Safe and Well Visit, Self-Determination

Recruiting
  • Accidental Fall
  • +2 more
  • Fire and Rescue Service Safe and Well Visit
  • +2 more
  • Hull, East Yorkshire, United Kingdom
  • +1 more
Jun 21, 2022

Bullous Pemphigoid Trial in Worldwide (biological, other, drug)

Recruiting
  • Bullous Pemphigoid
  • efgartigimod PH20 SC
  • +2 more
  • Fountain Valley, California
  • +24 more
Jul 27, 2022

Low Back Pain Trial in Worldwide (Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005)

Completed
  • Low Back Pain
  • Matching Placebo
  • +4 more
  • Senftenberg, Austria
  • +78 more
Jul 13, 2021

Patients With nAMD in UK Routine Clinical Practice

Recruiting
  • Neovascular Age-related Macular Degeneration
  • brolucizumab
  • Peterborough, Cambridgeshire, United Kingdom
  • +12 more
Jul 18, 2022

Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

Terminated
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2022

Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

Recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • Aberdeen, United Kingdom
  • +6 more
May 24, 2022

Cancer Trial in Germany, United Kingdom (Sativex, Placebo)

Completed
  • Cancer
  • Aachen, Germany
  • +10 more
Dec 19, 2022

Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • efgartigimod PH20 SC
  • Carlsbad, California
  • +46 more
Jul 5, 2022

Adult Growth Hormone Deficiency Trial in Worldwide (somavaratan)

Completed
  • Adult Growth Hormone Deficiency
  • Escondido, California
  • +17 more
Jul 22, 2022

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)

Completed
  • Generalized Myasthenia Gravis
  • efgartigimod PH20 SC
  • efgartigimod IV
  • Carlsbad, California
  • +46 more
Jan 31, 2022

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • Birmingham, Alabama
  • +120 more
Dec 22, 2022

Venous Leg Ulcer Trial in Worldwide (Venous Leg Ulcer Standard of Care with Granulox)

Active, not recruiting
  • Venous Leg Ulcer
  • Venous Leg Ulcer Standard of Care with Granulox
  • Split, Croatia
  • +26 more
Jan 16, 2023

Recurrence After Whipple's (RAW) Study

Active, not recruiting
  • Pancreatic Cancer
  • +13 more
  • Pancreaticoduodenectomy
  • Clayton, Victoria, Australia
  • +28 more
Jan 13, 2023

Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

Completed
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Truro, Cornwall, United Kingdom
  • +35 more
May 18, 2022

Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

Recruiting
  • Eye Diseases
  • +2 more
  • Pars plana vitrectomy
  • +3 more
  • Chelmsford, Essex, United Kingdom
  • +13 more
Aug 2, 2022

Anemia, End Stage Renal Disease (ESRD) Trial in Worldwide (Roxadustat, Epoetin alfa, Darbepoetin alfa)

Completed
Has Results
  • Anemia
  • End Stage Renal Disease (ESRD)
  • Brussels, Flemish Brabant, Belgium
  • +142 more
Jan 14, 2021

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Advanced Solid Tumor Trial in Australia, China, Hong Kong (HBM4003)

Active, not recruiting
  • Advanced Solid Tumor
  • Kogarah, New South Wales, Australia
  • +16 more
Aug 2, 2022

Surfactant Dose on Outcomes in Preterm Infants With RDS

Completed
  • Respiratory Distress Syndrome
  • Bronchopulmonary Dysplasia
    • Ashford, Kent, United Kingdom
    • +28 more
    Feb 18, 2022

    COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • AZD2816
    • Brasilia, Brazil
    • +34 more
    Jun 27, 2022

    Trauma Injury Trial in United Kingdom, United States (Cryoprecipitate, Red Blood Cells, Plasma)

    Active, not recruiting
    • Trauma Injury
    • Cryoprecipitate
    • +4 more
    • Houston, Texas
    • +24 more
    Jan 13, 2022